3rd party tested bpc-157 – Research Peptide BPC-157 - Research Grade Peptide
Description
What We Don't Know: No human clinical trials yet
This approach suits specific situations like demanding cognitive work periods, recovery from illness, or addressing acute cognitive symptoms
Journal of applied physiology
It also reduced expression of Lymphocyte function-associated antigen 1 (LFA-1) and CD44 and regulated Jun-N terminal kinase (JNK) in the reduction of the apoptosis of T cells
